top of page

Free UK delivery on all orders over £50.00

Writer's pictureChris Makin

£13.7m of Potential Cost Savings

We have recently completed an exercise to calculate the potential savings from switching prescriptions of the following prescribed medical appliances to an equivalent supplied by Apollo Medical Technologies Ltd:


  • Insulin Pen Needles

  • Safety Insulin Pen Needles

  • Dual Safety Insulin Pen Needles

  • Lancets

  • Safety Lancets


By using the NHSBSA prescribing data for August 2024 obtained from their open data portal, we have calculated that NHS ICB's in England could save an average of 36.58% on their prescribing costs of the above medical appliances.


The savings potential equates to £1,144,796.43 per month with a calculated annual saving of £13,737,227.10 over the 42 ICB's in England.


One trust could save a massive 43.55% on their prescription costs on the above medical appliances.


The potential savings could be better used in other areas of the NHS to improve patient outcomes and we are happy to work with any medical provider to help reduce their costs on consumable medical appliances.


Please view our results table document for the savings data calculated for the 42 ICB's in England. If you would like anymore information on the potential cost savings provided by our products, please get in touch and we will be happy to provide and discuss this with you.





1 view0 comments

Comments


bottom of page